Soleno Therapeutics, Inc. - Rasio total nilai perusahaan marang pendapatan SLNO

Soleno Therapeutics, Inc. (SLNO) - logo korporat

Anticipation of drug approvals caused a cash deficit, which triggered a spike on the Soleno Therapeutics (SLNO) EV/Sales chart. The 8987.61 metric confirms the current level of market valuation. Business stability is based on outsourcing production through contract manufacturing plants, while intellectual potential is provided by high-paid endocrinologists creating unique medications for rare metabolic pathologies.

SLNO Soleno Therapeutics: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 30.05.2026

SLNO (soleno.life): rincian analitis lan laporan miturut indikator

- rega saham lan prakiraan rega para ahli:
- indikator dhuwit lan arus kas:
Analisis wiwitan perusahaan:Soleno Therapeutics - SLNO
Produk asli Soleno Therapeutics

This indicator determines the enterprise value of the entire business, accounting for net debt, and compares it to sales volume to identify whether the asset is overvalued or undervalued. By analyzing the ratio of enterprise value to annual revenue, an investor can see the premium for the monopoly status of Soleno Therapeutics (SLNO), driven by the patent protection of orphan drugs, which makes the asset resilient to competition and justifies high multiples.

Analisis pesaing Soleno Therapeutics

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|FOLD - Rasio nilai perusahaan marang pendapatan|ETNB: Rasio nilai perusahaan marang pendapatan|AGIO: Multiplikator EV/Sales|Structure Therapeutics Inc. - Nilai bisnis marang pendapatan|MDXG (MiMedx Corp) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Rezolute Inc RZLT|Multiplikator EV/Sales LXRX|Rasio total nilai perusahaan marang pendapatan MBX Corp|Altimmune Pharma - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales aardvarktherapeutics.com AARD|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)